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Abstract
Obesity and type 2 diabetes lead to dramatically increased risks of atherosclerosis and CHD. Multiple mechanisms converge to promote
atherosclerosis by increasing endothelial oxidative stress and up-regulating expression of pro-inflammatory molecules. Microvesicles
(MV) are small (,1mm) circulating particles that transport proteins and genetic material, through which they are able to mediate cell–
cell communication and influence gene expression. Since MV are increased in plasma of obese, insulin-resistant and diabetic individuals,
who often exhibit chronic vascular inflammation, and long-term feeding of a high-fat diet (HFD) to rats is a well-described model of obesity
and insulin resistance, we hypothesised that this may be a useful model to study the impact of MV on endothelial inflammation. The
number and cellular origin of MV from HFD-fed obese rats were characterised by flow cytometry. Total MV were significantly increased
after feeding HFD compared to feeding chow (P,0·001), with significantly elevated numbers of MV derived from leucocyte, endothelial
and platelet compartments (P,0·01 for each cell type). MV were isolated from plasma and their ability to induce reactive oxygen species
(ROS) formation and vascular cell adhesion molecule (VCAM)-1 expression was measured in primary rat cardiac endothelial cells in vitro.
MV from HFD-fed rats induced significant ROS (P,0·001) and VCAM-1 expression (P¼0·0275), indicative of a pro-inflammatory MV
phenotype in this model of obesity. These findings confirm that this is a useful model to further study the mechanisms by which diet
can influence MV release and subsequent effects on cardio-metabolic health.
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The prevalence of both obesity and type 2 diabetes (T2D) has
increased dramatically in recent decades worldwide. Both
conditions represent substantial risk factors for the develop-
ment of atherosclerotic disease and the resulting increased
incidence of myocardial infarction and stroke(1). Atherosclero-
sis is a chronic inflammatory disease of the large arteries that
involves in its earliest stages a non-resolving pro-inflammatory
activation of the vascular endothelium, leading to platelet
adherence, and activation, adhesion and trans-endothelial
migration of monocyte subsets, which then differentiate into
macrophages within the developing neointima(2).
The development of vascular inflammation and oxidative
stress are two key mechanisms involved in endothelial dys-
function and atherosclerosis progression in obesity and T2D
and both are promoted independently by hyperglycaemia
and insulin resistance (IR)(3,4). High glucose concentra-
tions, chronic hyperinsulinaemia and obesity, all promote
pro-inflammatory gene expression(5,6) and endothelial NO
synthase uncoupling in endothelial cells, resulting in increased
reactive oxygen species (ROS), reduced NO and a reduction
in endothelial-dependent relaxation and associated vascular
changes(7–9).
Extracellular vesicles are small (,1mm) circulating vesicles
that can be classified as smaller exosomes (80–100 nm),
released by an endosomal pathway(10–12) or larger, more
heterogeneous microvesicles (MV; 100–1000 nm). These are
released from cells including endothelial cells, leucocytes,
platelets and erythrocytes by blebbing of the plasma mem-
brane during activation and apoptosis(10–12). Plasma MV are
increased during disease processes, including cancer, CVD
and autoimmunity (for reviews see Diamant et al.(15),
Tramontano et al.(16), Chen et al.(17)). MV can be identified
by the presence of exposed phosphatidyl serine on their
plasma membranes and by the presence of surface markers
referable to their parent cells. They can bind to cells using
membrane receptors and contain ‘cargo’ such as proteins,
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mRNA and microRNA, which they can deliver to recipient
cells and thus activate intracellular signalling pathways
and gene transcription. Thus, MV may be useful plasma
biomarkers as well as contributing to disease processes by
altering signal transduction(12).
Chronic inflammation of the endothelium may be one
of the triggers for MV release from circulating cells. Our
previous work demonstrated release of pro-oxidant, pro-
coagulant leucocyte, platelet and erythrocyte-derived MV in
whole blood flowing over inflamed endothelium that could
induce ROS formation in quiescent endothelium(13,14).
Increased numbers of MV have been identified in the
plasma of patients with elevated plasma LDL-cholesterol,
obesity, metabolic syndrome and T2D, all of which represent
risk factors for CVD(15–17).
The present study aims to determine whether a well-
described rodent model of obesity and IR, which has
previously been shown to have a pro-inflammatory
phenotype(18), also leads to production of increased numbers
of circulating pro-inflammatory MV. We used plasma
obtained from rats that had been fed a high-fat diet (HFD)
to identify the cellular origin of the MV released during obes-
ity and determined whether the purified MV could directly
induce pro-inflammatory changes in rat cardiac endothelial
cells (RCEC).
Methods
Animal model
The present study was approved by the Royal Veterinary
College’s Welfare and Ethics Committee and was carried out
under UK Home Office licenses to comply with the Animals
(Scientific Procedures) Act 1986. Six-week-old male Wistar
rats (Charles River) were maintained at 22 ^ 0·58C under a
12 h light–12 h dark cycle. Ten were fed a standard mainten-
ance chow diet (Special Diet Services) and ten were fed a
HFD, providing 60 % energy as fat (RD12492; Research
Diets) ad libitum for 20 weeks. An intraperitoneal insulin tol-
erance test was conducted in overnight fasted rats to confirm
the development of IR. Briefly, blood glucose was measured
immediately prior (time ¼ 0) to an intraperitoneal injection
of 3 nmol/kg (0·5 IU/kg) insulin (Actrapid; Novo Nordisk),
and 15, 30, 60 and 90 min afterwards using an Accuchek
Aviva handheld glucometer (Roche). Plasma insulin concen-
tration was measured using a rat insulin RIA kit (Millipore)
at time 0. Body mass and epididymal fat pad mass were
recorded at euthanasia.
Blood was collected by cardiac puncture under terminal
anaesthesia with pentobarbitone and 1 ml was collected into
tubes containing 100ml 3·2 % sodium citrate, followed by
centrifugation at 2000 g for 1 min to separate plasma. Plasma
was collected, stored at 2808C and thawed on ice before use.
Materials
Phycoerythrin (PE)-IgGI k isotype control and fluorescein
isothiocyanate (FITC)-IgGI k isotype control, PE anti-CD31
(PECAM-1; used as endothelial marker) and PE anti-a/b
T-cell receptor (TCR; used as T cell marker) were from BD
Bioscience. PE anti-CD106 (vascular cell adhesion molecule-
1; VCAM-1; expressed by activated endothelial cells) was
from BioLegend. PE Cy7 annexin V (AnnV; to detect exposed
phosphatidyl serine), PE anti-CD45.2 (pan-leucocyte marker)
and PE anti- CD61 (integrin b3; platelet marker) were from
eBioscience. Fluorescein isothiocyanate anti-CD43 (pan-leu-
cocyte marker apart from B Cells), PE anti-CD11b (activated
leucocyte marker) and fluorescein isothiocyanate anti-macro-
phage antibody were from AbDSerotec.
Latex sizing beads (1·1mm) and Dihydrorhodamine 123 were
from Sigma and enumeration beads from Bangs Laboratories
(supplied by Stratech Scientific). Tissue culture medium was
from PAA or Sigma. Full endothelial cell medium (EC medium)
contained HEPES-buffered M199 supplemented with penicil-
lin/streptomycin, 2 mM-L-glutamine, 20 % fetal calf serum,
0·55 mg/ml heparin and 275mg/ml endothelial cell growth sup-
plement. 1 £ Tyrode’s buffer was prepared daily (139 mM-NaCl,
3 mM-KCl,17 mM-NaHCO3,3 mM-CaCl2,1 mM-MgCl2).AnnexinV
Binding buffer was from eBioscience. All buffers were passed
through 0·22mm syringe filters before use.
Enumeration and phenotyping of microvesicle populations
by flow cytometry
Flow cytometric analysis of the same volume of antibody-
labelled plasma from each animal was carried out as
described previously(13,14), using a FACS Canto II (BD
Biosciences), utilising three lasers, eight colours, a standard
optical filter setup and FACS Diva Software version 6.1 (BD
Biosciences). The instrument was calibrated daily using Cell
Tracker Beads (BD Biosciences). MV were identified by
their characteristic forward (FSC-A; indicates size of particles)
and side scatter (SSC-A; indicates granularity of particles) and
their ability to bind to cell-specific monoclonal antibodies.
Plasma samples were diluted 1:10 in Tyrode’s buffer and
50ml diluted plasma was incubated on ice with antibodies
or isotype controls. After 15 min, 450ml of Tyrode’s or
Annexin V binding buffer was added. 1·09mm latex beads
(Sigma) were added to each sample to allow detection of
particles ,1mm. 10ml Absolute Count beads (Bang’s Labo-
ratories) were added to each sample to allow internal
calibration of the number of events ,1·1mm according to
the following equation. Samples were acquired for 2 min
on a low flow rate (online Supplementary Fig. S1). Isotype
controls were used to adjust voltages for fluorescein isothio-
cyanate, PE or Cy-7 for each sample. Negative gates were set
to 1 % of total counts for fluorescence. A platelet-gate was
additionally plotted on the FSC/SSC plots according to the
characteristic ‘cloud’ of light-scatter characteristic of platelet
populations (online Supplementary Fig. S1(C)(13)). For each
phenotypic marker, MV were counted by reference to
enumeration beads:
MV density=ml ¼ ðnumber of enumeration beads added=
ml £ events counted £ dilution factorÞ=
ðnumber of enumeration beads countedÞ:
L. F. Heinrich et al.2
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Measurement of microvesicle-induced reactive
oxygen species in rat endothelial cells using
dihydrorhodamine 123
We conducted a small pilot study to determine a suitable
number of pro-inflammatory MV to add using THP-1 mono-
cytes (human monocyte cell line TIB202 available from the
American Type Culture Collection) that had been differen-
tiated with phorbol myristate acetate (PMA) 200 ng/ml for
72 h. Briefly, differentiated THP-1 (1 £ 106 per well) were
washed to remove non-adherent cells, and treated with
10mg/ml lipopolysaccharide (LPS) for 24 h (medium was
removed, cells washed and replaced with fresh medium
after 8 h to remove traces of unbound LPS). MV were analysed
by flow cytometry with enumeration beads as described in
Materials and Methods. Appropriate volumes of conditioned
medium from untreated or LPS-treated THP-1 macrophages
equating to final concentrations of 1000, 200, 100, 50 or
10 MV/ml were centrifuged at 17 000g for 15 min to pellet
MV and re-suspended in 500ml M199/10 % fetal calf serum.
Conditioned medium (100ml) was added to human umbilical
vein endothelial cells seeded onto white opaque ninety-six
well plates (2 £ 104 per well) and pre-loaded with 5mm dihy-
drorhodamine 123, followed by analysis on a fluorescent plate
reader (Wallac Victor 2 1420) after 24 h. LPS (10 mg/ml) was
added to human umbilical vein endothelial cells as a positive
control (online Supplementary Fig. S3). From this we deter-
mined that a minimum of 100 MV/ml of MV released from
inflamed cells was sufficient for eliciting ROS production
in EC. In contrast, up to 1000 MV/ml of MV from quiescent
cells had no effect on ROS.
Primary cultures of RCEC isolated from the PVG.AO-RT1m
strain were obtained from Professor Marlene Rose (Imperial
College, London) at no cost. RCEC were cultured in EC medium
and seeded at 25000 cells per well on white opaque ninety-
six well plates and allowed to adhere overnight. The culture
medium was replaced with EC medium containing 1mM-
dihydrorhodamine 123, followed by 10-min incubation in the
dark. Meanwhile, MV were isolated by centrifugation of 50ml of
each plasma sample at 17 000g for 15min at 48C. Pellets were
re-suspended in 500ml EC medium (a one in ten dilution from
the original plasma; approximately 900MV/ml from HFD-fed
rats was added to the cells) and added in triplicate. Fluorescence
was read at 0, 5, 10, 15, 30min, 1, 2, 4 and 24h on a fluorescent
plate reader (Wallac Victor 2 1420 Multilabel counter; Perkin
Elmer). Positive (1nM-H2O2) and negative (100ml of medium)
controls were also analysed (n 4 RCEC isolates).
Measurement of CD106 (vascular cell adhesion
molecule-1) expression in microvesicle-treated rat
cardiac endothelial cells
RCEC were seeded at 200 000 cells per well. The following
day MV were isolated by centrifugation of 50ml (approxi-
mately 50 000 MV in total) of each plasma sample at 17 000g
for 10 min at 48C. The supernatant was removed and the pellet
(containing MV) was re-suspended in 500ml EC medium (a
one in ten dilution from the original plasma–approximately
900 MV/ml from HFD-fed rats). Medium was removed from
adhered RCEC, replaced with MV-containing medium and
the cells were incubated overnight at 378C. Negative (medium
alone) and positive (LPS 100 ng/ml) controls were included.
RCEC were disaggregated with 1 £ trypsin/EDTA for 5 min.
Non-adherent cells were pelleted and incubated with anti-
CD106 or isotype control antibodies on ice for 20 min,
then FACS FIX (0·5 % formaldehyde in PBS) was added to each
tube and samples were immediately analysed. Median fluo-
rescence intensity for each sample was recorded (n 3 RCEC
isolates).
Statistical analysis
Data analysis was carried out using GraphPad Prism version 6
(GraphPad Software). All data are means with their standard
errors. A D’Agostino and Pearson omnibus normality test
was carried out on all MV data and consequently all were
analysed using Mann–Whitney U or Kruskal–Wallis tests fol-
lowed by Dunn’s multiple comparison test as appropriate.
For differences between the treatment groups across time
points, a two-way ANOVA was used, accompanied by the
Tukey post hoc test where appropriate. Correlation measure-
ments were carried out using Spearman’s correlation for
non-parametric data (r 2). Student’s t tests were used to com-
pare total rat and fat depot masses and plasma insulin and
two-way repeated measures ANOVA for intraperitoneal insulin
tolerance test data. P,0·05 was accepted as significant.
Results
High-fat diet feeding-induced obesity is associated
with increased phosphatidyl serine-positive
microvesicle release
Feeding of a HFD for 20 weeks resulted in increased body
mass (746 (SEM 20) v. 523 (SEM 30) g; P,0·001) and epididymal
fat pad mass as a percentage of body mass (3·11 (SEM 0·17) v.
1·44 (SEM 0·13) %: P,0·001) v. chow-fed rats, consistent with
the development of obesity. Fasting plasma insulin was also
increased in HFD- v. chow-fed rats (5·84 (SEM 0·46) v. 2·44
(SEM 0·35) ng/ml; P,0·001), while blood glucose concen-
trations were suppressed less effectively in HFD-fed rats
during an intraperitoneal insulin tolerance test (online
Supplementary Fig. S2), confirming the development of IR.
As shown in online Supplementary Fig. S1 and Fig. 1(a),
there were 12·7-fold more MV identified in the plasma of
HFD-fed rats compared with that in the plasma of chow-fed
rats (P,0·001). There was also an 8-fold higher Annexin V
binding to MV in HFD plasma than in chow plasma
(P,0·0001; Fig. 1(b)), indicative of increased phosphatidyl
serine exposure and loss of membrane asymmetry.
Increased numbers of CD45þ, CD43þ or TCRþ
microvesicles are released in rat obesity
The cellular sources of MV identified in Fig. 1 were character-
ised using fluorescently conjugated antibodies directed against
Effects of high fat feeding in rats 3
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CD43, CD45 or TCR, proteins expressed on the surface of
leucocytes (Fig. 2). CD45þ MV (pan-leucocyte marker) were
7·5-fold increased after HFD feeding (P¼0·0029; Fig. 2(a)).
Furthermore, MV expressing CD43, a marker of T-lymphocytes
and monocytes (2·5-fold, P¼0·0354; Fig. 2(b)), the antigen
recognised by MAC387 (a monocyte marker; 22-fold,
P¼0·0018; Fig. 2(c)), ab TCR (17·3-fold, P,0·0001; Fig. 2(d))
and CD11b (2·0-fold, P¼0·0147; Fig. 2(e)), were all increased
in obese rat plasma, indicating an effect of HFD feeding on all
major classes of leucocyte-derived MV, including those
released by activated cells. Furthermore, there was a signifi-
cant correlation between blood glucose level and numbers
of MAC387þ MV (r 0·789, P¼0·007) in HFD-fed rats (Fig. 2(f)).
Platelet and endothelial cell-derived microvesicles are
increased in plasma from obese rats
As shown in Fig. 3, plasma from HFD-fed rats contained 9·4-
fold more endothelial cell-derived CD31þMV/ml, compared
to chow-fed rats (P¼0·0185; Fig. 3(a)). In addition, VCAM-
1þMV, derived from activated EC, tended to be increased in
HFD- v. chow-fed rats (by 73 %, P¼0·088; Fig. 3(b)). Surpris-
ingly, Annexin Vþ platelet-derived MV (CD61þ) appeared to
be very rare in plasma from chow-fed rats (4 (SEM 1) MV/ml),
but were markedly more abundant in HFD plasma (1055
(SEM 609) MV/ml, P¼0·0039), therefore we reanalysed the
data to include both Ann Vþ and Ann V– CD61þ MV (174
(SEM 105) in chow-fed v. 1570 (SEM 1277) in HFD-fed plasma
P¼0·0281; Fig. 3(c)). To confirm that platelet-derived MV
were increased, the FSC/SSC plots were re-analysed to
determine the number of CD61þ (AnnVþ and Ann V2) MV
in the classic platelet cloud (129 (SEM 51·0) CD61þ MV/ml in
chow- and 349 (SEM 105) in HFD-fed rat plasma; P¼0·0039;
online Supplementary Fig. S1(C), Fig. 3(d)). There were
significant correlations between blood glucose level and
numbers of both CD31þ MV (r 2 0·645, P¼0·044) and CD61þ
MV (r 2 0·541, P¼0·0153) in HFD-fed rats (Fig. 3(e) and (f)).
Exposure of quiescent endothelial cells to microvesicles
derived from obese rats induces vascular cell adhesion
molecule-1 expression
VCAM-1 (CD106) is expressed by cytokine-activated endo-
thelium and is a marker of inflammation(2). As shown in
Fig. 4, incubation of RCEC with MV derived from plasma of
HFD-fed rats but not from chow-fed rats induced an increase
in VCAM-1 median fluorescence intensity on the cell surface
to a similar extent to that induced by positive control LPS
treatment (VCAM-1 increased by 59 % in HFD v. chow
endothelium; P¼0·0275).
Exposure of quiescent endothelial cells to microvesicles
derived from obese rats induces reactive oxygen species
formation
ROS formation was measured over 24 h using dihydrorhoda-
mine 123. At all time points H2O2 treatment led to increased
ROS formation v. either control or addition of MV, as expected
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Fig. 2. Leucocyte-derived microvesicles (MV) are increased in the plasma
of rats fed a high-fat diet (HFD) for 20 weeks. MV with leucocyte surface
markers were enumerated by flow cytometry in plasma samples from
chow-fed ( ) or HFD fed (B) rats. (a) CD45þ MV (pan-leucocyte marker).
(b) CD43þ MV (all leucocytes except for B cells). (c) Monocyte-derived MV
(MAC387 antigenþ). (d) TCRþ MV (T-cell marker). (e) CD11bþ MV (activated
leukocytes). n 9–10 rats/group. Values are means, with their standard errors
represented by vertical bars. Mean value was significantly different from that
of the chow-fed group: *P,0·05, **P,0·01, ****P,0·0001. (f) Correlation of
MAC387þ MV with glucose (mM). , MAC387þ MV HFD; , MAC387þ
MV chow. R 0·089 P¼0·007.
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Fig. 1. Annexin Vþ microvesicles (MV) are elevated in the plasma of rats fed
a high-fat diet (HFD) for 20 weeks. MV in plasma samples from chow-fed ( )
or HFD-fed (B) rats were enumerated by flow cytometry. (a) Total MV/ml
counted in each plasma sample using the gating strategy outlined in
Methods and illustrated in online Supplementary Fig. S1(A). (b) Annexin Vþ
MV. n 9–10 rats/group. Values are means, with their standard errors
represented by vertical bars. *** Mean value was significantly different from
that of the chow-fed group (P,0·001).
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(Fig. 5). However, after 24-h treatment, ROS production was
increased in HCEC treated with MV from HFD-fed rats com-
pared with the untreated control or chow MV (30 % increase
in HFD v. chow; P,0·0001).
Discussion
There is a growing literature demonstrating that chronic dis-
eases with an inflammatory component are characterised by
increased release of MV into plasma. In the present study,
we have used a well-characterised rodent model to show
that obesity is associated with substantially elevated numbers
of circulating MV, in agreement with data from recent studies
of human obesity and diabetes(15–17,19–21). In addition, pheno-
typic analysis of these MV revealed that they were derived
from endothelial cells (CD31þ), platelets (CD61þ), T cells
(TCRa/b) and monocytes (MAC387þ) – key cell populations
involved in the initiation and progression of atherosclerosis
whose numbers are also elevated in human cardio-metabolic
disease(17,22,23). Furthermore, the numbers of MV correlated
with the glucose levels in these animals, again consistent
with human studies(23). Recent studies (e.g. do Carmo
et al.(24)) suggest that long-term feeding of a HFD leads to
bone marrow hyperplasia and modulation of haematopoiesis,
which in turn leads to higher numbers of circulating leuco-
cytes, which could at least in part account for the observed
increase in circulating leucocyte MV in the HFD-fed rats.
Interestingly, we found a large proportion of the CD61þ MV
did not bind Annexin V, suggesting that HFD led to an
increase in platelet MV release due to increased turnover as
has been described in human samples(25) rather than acti-
vation and release of procoagulant MV.
The overall numbers of platelet-derived MV detected
are in agreement with another recent study carried out in
streptozotocin-treated rats(26). Interestingly, another study
that subjected younger rats (13 weeks old rather than 26
weeks old) to hypoxia described much higher numbers of
platelet-derived MV, both in control and in hypoxia-exposed
animals(27). This may reflect an age-dependent decline in the
release of MV from platelets in the rat, although this possibility
awaits confirmation.
MV were able to elicit pro-inflammatory effects in quiescent
endothelial cells, a finding consistent with the existing theory
that circulating MV do not merely represent a mechanism to
remove cellular debris from dying or activated cells, but
have functional importance in transcellular communication
during the progression of chronic inflammatory diseases,
and may be important for increasing endothelial dysfunction in
plaque-prone areas, a pre-requisite for atheroma formation(10).
The present work also highlights the usefulness of this rodent
model to further study the influence of diet on MV release
and the effects of MV on vascular inflammation. To our know-
ledge, this is the first study to demonstrate the potential
functional importance of elevated numbers of MV observed
in obesity for inciting endothelial inflammatory responses.
However, although we have shown a relationship between
plasma glucose and numbers of various MV subsets, it is
unclear as yet which of the obesity-associated metabolic,
endocrine or pro-inflammatory changes may be responsible
for the increased MV generation.
MV derived from cells of monocyte/macrophage lineage,
T cells, endothelial cells and platelets have been identified
in human atherosclerotic lesions(28) and shown to contribute
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Fig. 4. CD106 (vascular cell adhesion molecule-1 (VCAM-1)) expression is
increased on endothelial cells treated with microvesicles (MV) from high-fat
diet (HFD) fed rats. MV from chow-fed rats ( ) or HFD-fed rats (B) for 20
weeks were isolated from plasma by centrifugation at 17 000g and used to
stimulate primary cultures of rat cardiac endothelial cells for 18 h. VCAM-1
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was analysed by flow cytometry. 10 ng/ml lipopolysaccharide (LPS) used as
a positive control (hatched), n 3 RCEC isolates. Values are means, with their
standard errors represented by vertical bars. * Mean value was significantly
different from that of the chow-fed group (P,0·05). a.u., Arbitrary units.
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Fig. 3. CD31þ and CD61þ microvesicles (MV) are raised in the plasma of
rats fed a high-fat diet (HFD) for 20 weeks. CD31þ (endothelial) MV (a, b) or
CD61þ(platelet) (c, d) surface markers were enumerated by flow cytometry
in plasma samples from chow-fed ( ) or HFD-fed (B) rats. (a) CD31þ MV
(endothelial cell marker). (b) CD106þ MV (activated endothelial cells).
(c) CD61þ MV (platelets). (D) CD61þ MV in platelet gate illustrated in online
Supplementary Fig. S1(C). n 9–10 rats/group. Values are means, with their
standard errors represented by vertical bars. Mean value was significantly
different from that of the chow-fed group: *P,0·05, **P,0·01. † Mean value
was marginally significantly different from that of the chow-fed group
(P,0·1). (e) Correlation of CD31þ MV in HFD plasma and glucose R 0·645
P¼0·044. , CD31þ MV HFD; , CD31þ MV chow. (f) Correlation of
CD61þ MV in HFD plasma with glucose (mM). , CD61þ MV chow; ,
CD61þ MV HFD. R 2 0·541, P¼0·0153.
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to plaque instability, in part by promoting monocyte adhesion
and trans-endothelial migration via enhanced surface expre-
ssion of endothelial intercellular adhesion molecule-1(29).
In the present study, MV derived from HFD-fed rats induced
VCAM-1 expression, which is another key adhesion molecule
involved in firm adhesion and trans-endothelial migration
of monocytes in rodent models of atherosclerosis(30). Further
work is required to determine the full extent of pro-
inflammatory gene expression up-regulated by MV derived
from HFD- v. chow-fed rats.
It is likely that the individual species of MV present in the
mixed populations isolated from patients or animal models
have disparate effects, but together have a net pro- or anti-
atherogenic effect on endothelia. Further work is required to
dissect the responses elicited by individual MV species in
order to fully understand how they contribute to vascular
inflammation and atherosclerosis. However, it is still not tech-
nically possible to satisfactorily separate in vivo generated MV
to determine their function. We have previously developed an
in vitro flow system to model interactions between blood and
inflamed endothelium under haemodynamic flow conditions
and showed that this leads to enhanced release of MV from
leucocytes, platelets and erythrocytes. Furthermore, these
MV were able to induce ROS in quiescent endothelium,
suggesting that they are similar to in vivo generated
MV(13,14). Using isolated blood cells from animals fed a
defined HFD or from T2D patients, and autologous isolated
endothelial cells (rodent) or explanted blood vessels (from
diabetic peripheral arterial disease amputees) it should in
future be possible to determine more accurately the role of
individual species of MV in endothelial dysfunction.
One of the limitations to the present study is that only
one subset of extracellular vesicles was measured, namely,
the MV population .200 nm in diameter, due to difficulties
distinguishing smaller particles from background noise by
conventional flow cytometry. It is likely that in addition to
release of the larger MV there is also increased production
of pro-inflammatory exosomes and smaller (,200 nm) MV,
in development of obesity and IR in this rodent model in
agreement with human studies(31). A number of methods for
exosome measurement and isolation have been described
recently, including Nanotracking analysis and dynamic light
scattering (for review see Yellon & Davidson(32), Mulcahy
et al.(33)). However, at the present time, it is not possible to
identify the cellular sources of exosomes, and nanotracking
analysis and DLA do not easily enable identification of the cel-
lular source of MV, thus flow cytometric analysis is currently
the most established technology for immune-phenotyping of
MV released by inflamed and activated cells. In addition, we
utilised frozen and thawed plasma samples. Recent studies
by several groups have recommended analysis of fresh
plasma or whole blood for extracellular vesicle analysis; how-
ever, use of citrate as anti-coagulant followed by freezing of
plasma at 2808C has been shown to be an acceptable alterna-
tive (for recent reviews see Lacroix et al.(34), van der Meel
et al.(35)). We used MV from a similar volume of plasma
from HFD- or chow-fed rats for our functional studies. This
was based on pilot studies with MV derived from single
(human) cell types in tissue culture experiments, which
suggested that the number of MV added is not a significant
factor for their pro-inflammatory or other effects (online Sup-
plementary Fig. S3), but instead the stimulus that has been
used to generate the MV is more important. A similar approach
has been taken in other studies where numbers of MV
approximating to those found circulating have been added(27).
Obesity and IR induce oxidative stress and inflammation in
the endothelium, features of endothelial dysfunction that pre-
dispose to atherosclerotic lesion formation(3,4). Furthermore,
endothelial cells from T2D patients display defective insulin
signalling, increased nitrotyrosine, ROS and increased NF-kB
p65 and intercellular adhesion molecule-1 expression(36). It
is possible that increased VCAM-1 expression is mediated by
the observed ROS production, which might be downstream
of RAC activation (for review see Marcos-Ramiro et al.(37)).
Although limitations in the plasma sample volume collected
from each animal prevented us from investigating this mech-
anism during the present study, it could be investigated
using ROS scavengers or dominant negative RAC constructs
in in vitro experiments. It is likely that these effects are also
mediated at least in part by chronic activation of protein
kinase C, which has been described in micro- and macro-
vascular tissue and circulating leucocytes in human T2D and
rodent models(36).
In agreement with this, protein kinase C is activated during
culture of rat aortic endothelial cells, smooth muscle cells
and circulating monocytes in hyperglycaemic conditions(38).
Protein kinase C activation is associated with phospha-
tidyl serine externalisation and CD43 expression on MV in
neutrophils(39), suggesting a direct link between IR and
increased levels of circulating MV. Endothelial and platelet-
derived MV identified in the plasma of patients with metabolic
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Fig. 5. Reactive oxygen species (ROS) induction in rat endothelial cells by
microvesicles (MV) from chow- or high-fat diet (HFD)-fed rats. MV were
isolated from plasma by centrifugation at 17 000g and used to stimulate
primary cultures of rat cardiac endothelial cells that had been loaded with
dihydrorhodamine 123. MV from rats fed chow ( ) or HFD ( ) for 20
weeks. 1 nM-hydrogen peroxide used as a positive control ( ), untreated
( ); n 4 RCEC isolates. Two-way non-parametric ANOVA followed by
Tukey. Values are means, with their standard errors represented by vertical
bars. **** Mean value was significantly different from that of the chow-fed
group at 24 h after treatment (P,0·0001). ‡‡‡‡ Mean values for the hydro-
gen peroxide-treated group were significantly higher than for all other groups
at all time points (P,0·0001).
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syndrome have also been shown to have a pro-oxidant effect
on endothelium, inducing NO and ROS production(40).
Hyperglycaemia and impaired insulin signalling leading
to endothelial inflammation and protein kinase C activation
could contribute to the increased numbers of circulating MV
observed in obese rats and human subjects. Moreover, given
that oxidative stress and pro-inflammatory gene expression
are key characteristics of diabetic endothelial dysfunction(3,4)
and our findings that MV from HFD-fed rats lead to increases
in both ROS and VCAM-1 expression, we and others have
proposed that MV released from multiple cell types under
diabetogenic conditions are functional particles that contribute
to systemic vascular inflammation and endothelial dysfunc-
tion, leading to macrovascular changes and potentially the
accelerated atherosclerotic lesion progression that is observed
in T2D(17,22,23). Further work is required to determine the
exact mechanisms leading to MV release under diabetogenic
conditions, and the rat model used in the present study may
prove useful to help determine how MV release and their
functional properties can be altered in a physiologically
relevant in vivo context, in response to dietary composition
or therapeutic substances.
Supplementary material
To view supplementary material for this article, please visit
http://dx.doi.org/10.1017/S0007114515001117
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